We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Final Guideline Outlines Requirements for Fixed-Combination Drugs
EMEA Final Guideline Outlines Requirements for Fixed-Combination Drugs
March 17, 2009
A European Medicines Agency (EMEA) final guideline recommends confirmatory clinical trials to demonstrate the efficacy of fixed-combination drug products, preferably by parallel group comparisons.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor